I favor biotech stocks trading below cash value after setbacks; Arvinas (ARVN) fits this description, dropping 25% on Thursday after ending two Phase 3 trials. ARVN's net cash per share is over $12, ...

This player's pipeline should keep growth going over the long run.

Zhengye receives a Nasdaq notice for failing to file its 2024 annual report on time. The company has 60 days to submit a compliance plan to avoid potential delisting. Get special access to three ...

Shares of Fortress Biotech rose after the company said it has agreed to sell a Rare Pediatric Disease Priority Review Voucher for gross proceeds of $205 million. Shares were up 14% to $3.84 in Monday ...

TRINITY BIOTECH ($TRIB) is expected to release its quarterly earnings data on Thursday, May 22nd before market open, per Finnhub. Analysts are expecting revenue of ...

(Bloomberg) -- The stock market’s recent wipeout has pushed a quarter of biotechnology stocks to trade below their cash holdings. That’s left bargain-hunters with a choice: Buy the dip or sit this one ...

(RTTNews) - Several small- and mid-cap stocks posted notable gains in Wednesday's after-hours trading session, even though most companies did not release fresh news. The movement was largely driven by ...

ASX biotech Botanix pauses trading ahead of a funding update. The post This ASX biotech just entered a trading halt. Here's ...

Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “hold” rating reissued by research analysts at Jones Trading in a report released on Friday,Benzinga reports. Several other equities ...

SAN DIEGO and CALGARY, AB, July 22, 2025 /PRNewswire/ -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a leading clinical-stage company specializing in ...

Kane Biotech Inc. (CVE:KNE – Get Free Report) shares fell 23.1% during mid-day trading on Saturday . The stock traded as low as C$0.05 and last traded at C$0.05. 159,625 shares changed hands during ...